Physician profile
Donald L Hembree
NPI 1366436636
$1,556.17
in general payments reported to CMS, 2019-2025
9 companies · $360 in 2025
The $360 reported for 2025 was more than what 76% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $89.43 · 2021: $421 · 2022: $422 · 2023: $92.29 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $488.04 | 2019-2023 | Acuvue |
| Alcon Vision LLC | $258.20 | 2020-2022 | |
| Sight Sciences, INC. | $244.38 | 2022-2025 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $115.78 | 2019-2021 | |
| Dompe US, INC. | $114.51 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $110.78 | 2025 | |
| Abbvie INC. | $108.24 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $60.05 | 2019 | |
| Astellas Pharma US INC | $56.19 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Hembree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.